Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

비호지킨림프종 환자의 발열성 호중구감소증에 대한 페그필그라스팀의 예방효과Prophylactic Effect of Pegfilgrastim on Febrile Neutropenia in Patients with Non-Hodgikin’s Lymphoma

Other Titles
Prophylactic Effect of Pegfilgrastim on Febrile Neutropenia in Patients with Non-Hodgikin’s Lymphoma
Authors
조주희방준석
Issue Date
Jun-2015
Publisher
한국임상약학회
Keywords
pegfilgrastim; febrile neutropenia; non-hodgikin' s lymphoma; R-CHOP regimen; granulocyte colony stimulating factor; risk factor
Citation
한국임상약학회지, v.25, no.2, pp.80 - 93
Journal Title
한국임상약학회지
Volume
25
Number
2
Start Page
80
End Page
93
URI
https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/5440
ISSN
1226-6051
Abstract
Objective: Pegfilgrastim is recently introduced that is long acting G-CSF for prophylaxis of febrile neutropenia. Treatment of non- Hodgikin's lymphoma (NHL) with R-CHOP is classified with relative high risk of febrile neutropenia. The study evaluated the prophylactic effect of pegfilgrastim to reduce the incidence of febrile neutropenia associated with R-CHOP of patient in NHL. And the risk factors associated with the incidence of FN and related events were evaluated. Methods: This retrospective study reviews the Electronic Medical Record of 68 NHL patients who received R-CHOP chemotherapy in single center between September 2013 and August 2014. These patients were classified who receive prophylaxis pegfilgrastim or no prophylaxis. Results: Sixty eight patients received R-CHOP with NHL. In 144 cycles of patients receiving pegfilgrastim, compared with no prophylaxis 178 cycles, had a lower incidence of febrile neutropenia (5.5% vs. 23.6%, p = 0.001), grade 3 or grade 4 neutropenia (14.4% vs. 89.8%, p < 0.001) and neutropenia related events (p < 0.05). The risk of febrile neutropenia after prophylaxis was significantly associated with age ≥ 65 (OR: 5.87, 95% CI 1.07-32.27, p = 0.042), IPI ≥ 3 (OR: 7.2, 95% CI 1.31-39.6, p = 0.023), S.alb < 3.5 g/dL (OR: 31.01, 95% CI 6.32-152.17, p < 0.0001). In multiple logistic regression analysis, lower baseline serum albumin (OR: 21.1, 95% CI 3.8-116.98, p = 0.001) was significantly associated with occurrence of febrile neutropenia. Conclusion: The study recommends prophylactic pegfilgrastim through risk assessment of febrile neutropenia in patients with non-Hodgikin's lymphoma receiving R-CHOP.
Files in This Item
Go to Link
Appears in
Collections
약학대학 > 약학부 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Bang, Joon Seok photo

Bang, Joon Seok
약학대학 (약학부)
Read more

Altmetrics

Total Views & Downloads

BROWSE